Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | PRKCI | P41743 | 17/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5798171 | 0.95 | MEN1 (0.46) | MEN1KMT2AMAPTHTTSMN1; SMN2 | |
| SCHEMBL5799122 | 0.87 | MAPT (0.48) | MEN1KMT2AMAPTHTTSMN1; SMN2 | |
| SCHEMBL5802431 | 0.86 | PRKCI (0.47) | HTTSMN1; SMN2PRKCI | |
| SCHEMBL5802365 | 0.86 | MEN1 (0.54) | MEN1KMT2AMAPTHTTSMN1; SMN2 | |
| SCHEMBL5780827 | 0.85 | PRKCI (0.62) | PRKCI | |
| SCHEMBL5801076 | 0.85 | PDE5A (0.57) | MEN1KMT2AMAPTHTTSMN1; SMN2 | |
| SCHEMBL5128684 | 0.84 | ALDH1A1 (0.48) | MEN1KMT2AMAPTSMN1; SMN2PRKCI | |
| SCHEMBL5781173 | 0.83 | MEN1 (0.52) | MEN1KMT2AMAPTHTTSMN1; SMN2 | |
| SCHEMBL5800559 | 0.83 | PRKCI (0.48) | MEN1KMT2AMAPTHTTSMN1; SMN2 | |
| SCHEMBL8205062 | 0.83 | PRKCI (0.46) | MEN1KMT2AMAPTHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1685136-A1 | USE OF THIENOPYRIMIDINES | MERCK PATENT GmbH (DE) | 2006-08-02 | — | — | EP | disclosed |
| WO-2005047292-A1 | USE OF THIENOPYRIMIDINES | MERCK PATENT GMBH (DE) | 2005-05-26 | — | — | WO | disclosed |
| US-6110920-A | TREATMENT OF CARDIOVASCULAR DISORDERS AND IMPOTENCY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2000-08-29 | — | — | US | disclosed |